FDA applicant

MicroPort NeuroTech (Shanghai) Co., Ltd.

Shanghai, CN4 decisions2021–20260 recalls

FDA records 4 decisions for MicroPort NeuroTech (Shanghai) Co., Ltd. (Shanghai, CN) from 2021 to 2026: 4 510(k) clearances. All are in product code HCG (Device, Neurovascular Embolization). Since 2016 its 510(k)s took a median of 109 days from receipt to decision, against 49 for FDA’s reviews in the same codes and years. Its devices cite 5 predicates, 3 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, neurology panel, where it files most

How often FDA has decided MicroPort NeuroTech (Shanghai) Co., Ltd.’s devices, and how often a recall has named them.

FDA decisions per year

2in 2024

2021high 2 (2024) · low 0 (2022)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2021.

FIG. 1 — MicroPort NeuroTech (Shanghai) Co., Ltd. by year, 2021–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like MicroPort NeuroTech (Shanghai) Co., Ltd.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “MicroPort”

FDA records each applicant name separately; these may or may not be the same firm.

Microport Orthopedics, Inc. 42 MicroPort CRM USA, Inc. 7 Microport Navibot International, LLC 1 Microport Orthopedics Inc. (Mpo) 1

MicroPort NeuroTech (Shanghai) Co., Ltd.

Which product codes does it file in?

How long do its 510(k) reviews take?

Whose devices does it build on?

Which of its devices are cited most?

What has FDA decided for it lately?

Other applicant names beginning “MicroPort”